Ascentage Pharma Group International (AAPG) Receivables - Net (2023 - 2026)

Ascentage Pharma Group International's Receivables - Net history runs 3 years deep, the most recent figure standing at $35.7 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 208.1% year-over-year to $35.7 million; the TTM figure through Dec 2025 stood at $35.7 million (up 208.1% YoY), while the FY2025 annual figure was $36.2 million, up 217.56% from the prior year.
• Receivables - Net for Q4 2025 stood at $35.7 million, up from $10.9 million in the prior quarter.
• The five-year high for Receivables - Net was $35.7 million in Q4 2025, with the low at $10.9 million in Q2 2025.
• The 3-year median for Receivables - Net is $15.9 million (2023), against an average of $19.6 million.
• The sharpest annual moves came in 2024 and 2025: Receivables - Net slumped 42.88% in 2024, then jumped 208.1% in 2025.
• Ascentage Pharma Group International's Receivables - Net stood at $20.3 million in 2023, then sank by 42.88% to $11.6 million in 2024, then surged by 208.1% to $35.7 million in 2025.
• Business Quant data shows AAPG's Receivables - Net at $35.7 million in Q4 2025, $10.9 million in Q2 2025, and $11.6 million in Q4 2024.